HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$40.60
Day range
$38.35 - $40.16
Year range
$20.28 - $99.41
Market cap
4.38B USD
Avg Volume
3.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.56M | 34.08% |
Net income | -24.94M | -10.68% |
Net profit margin | — | — |
Earnings per share | -0.22 | 4.35% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 930.44M | 147.30% |
Total assets | 937.89M | 145.10% |
Total liabilities | 26.44M | 83.32% |
Total equity | 911.45M | — |
Shares outstanding | 111.44M | — |
Price to book | 4.96 | — |
Return on assets | -9.70% | — |
Return on capital | -9.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.94M | -10.68% |
Cash from operations | -21.96M | -11.72% |
Cash from investing | 25.90M | 306.65% |
Cash from financing | 2.52M | 3,508.11% |
Net change in cash | 6.43M | 119.89% |
Free cash flow | -16.07M | -43.86% |
About
CEO
Founded
2012
Website
Employees
31
